{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:13:28Z","timestamp":1788783208646,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16348-w","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:27:13Z","timestamp":1782221233000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Betel nut chewing influences pathologic response in oral squamous cell carcinoma treated by neoadjuvant immunochemotherapy"],"prefix":"10.1186","volume":"26","author":[{"given":"Ran","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"16348_CR1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/medsci11020042","volume":"11","author":"A Barsouk","year":"2023","unstructured":"Barsouk A, Aluru JS, Rawla P, Saginala K, Barsouk A, Epidemiology. Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma. Med Sci (Basel). 2023;11:42.","journal-title":"Med Sci (Basel)"},{"key":"16348_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40463-023-00632-x","volume":"52","author":"HP Lee","year":"2023","unstructured":"Lee HP, Lee CC. Prognostic stratification of oropharyngeal cancer patients in a betel nut chewing and low HPV area. J Otolaryngol Head Neck Surg. 2023;52:27.","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"16348_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/odi.14943","author":"AG Singh","year":"2024","unstructured":"Singh AG, Chaturvedi P. Areca nut and oral cancer. Oral Dis. 2025;31:1467\u201372. https:\/\/doi.org\/10.1111\/odi.14943.","journal-title":"Oral Dis"},{"key":"16348_CR4","doi-asserted-by":"publisher","first-page":"102526","DOI":"10.1016\/j.canep.2024.102526","volume":"89","author":"MJ Su","year":"2024","unstructured":"Su MJ, Ho CH, Yeh CC. Association of alcohol consumption, betel nut chewing, and cigarette smoking with mortality in patients with head and neck cancer among the Taiwanese population: A nationwide population-based cohort study. Cancer Epidemiol. 2024;89:102526.","journal-title":"Cancer Epidemiol"},{"key":"16348_CR5","first-page":"268","volume":"30","author":"XJ Shao","year":"2021","unstructured":"Shao XJ, Zhu Q, Liu Y, Han XD, Lin XZ, Xi Q. [Correlation of betel nut chewing and clinicopathologic factors of oral squamous cell carcinoma]. Shanghai Kou Qiang Yi Xue. 2021;30:268\u201372.","journal-title":"Shanghai Kou Qiang Yi Xue"},{"key":"16348_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12957-016-0844-2","volume":"14","author":"YY Su","year":"2016","unstructured":"Su YY, Chien CY, Luo SD, Huang TL, Lin WC, Fang FM, Chiu TJ, Chen YH, Lai CC, Hsu CM, Li SH. Betel nut chewing history is an independent prognosticator for smoking patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil. World J Surg Oncol. 2016;14:86.","journal-title":"World J Surg Oncol"},{"key":"16348_CR7","doi-asserted-by":"publisher","first-page":"106760","DOI":"10.1016\/j.oraloncology.2024.106760","volume":"152","author":"RL Hong","year":"2024","unstructured":"Hong RL, Yen CJ, Lien MY, Cheng R, Su YW, Lin HN, Poon SL, Chien CY. Betel-nut chewing does not influence PD-L1 expression rates in recurrent\/metastatic head and neck squamous cell carcinoma (HNSCC): A prospective biomarker prevalence study. Oral Oncol. 2024;152:106760.","journal-title":"Oral Oncol"},{"key":"16348_CR8","doi-asserted-by":"publisher","first-page":"106768","DOI":"10.1016\/j.oraloncology.2024.106768","volume":"152","author":"L Lorini","year":"2024","unstructured":"Lorini L, Gili R, Salvestrini V, Morelli I, Smussi D, Petrelli F, Bonomo P, Bossi P. De novo metastatic head and neck squamous cell carcinoma: Why does locoregional control always. matter? Oral Oncol. 2024;152:106768.","journal-title":"matter? Oral Oncol"},{"key":"16348_CR9","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1097\/JS9.0000000000000489","volume":"109","author":"Y Huang","year":"2023","unstructured":"Huang Y, Sun J, Li J, Zhu D, Dong M, Dou S, Tang Y, Shi W, Sun Q, Zhao T, Zhou Z, Zhou X, Liu Y, Li J, Zhu G, Zhang D, Chen Y, Zhu Q, Ju W, Zhong L. Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial). Int J Surg. 2023;109:2220\u20137.","journal-title":"Int J Surg"},{"key":"16348_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hed.27915","volume":"47","author":"Z Yao","year":"2025","unstructured":"Yao Z, Wang J, Jiang Y, Zhang Y, Liu J, Dai L, Shen S, Zhou X, Liu Q, Zheng L, Qian M, Li J. Pembrolizumab plus cetuximab with neoadjuvant chemotherapy for head and neck squamous cell carcinoma. Head Neck. 2025;47:289\u201399.","journal-title":"Head Neck"},{"key":"16348_CR11","doi-asserted-by":"publisher","first-page":"7348","DOI":"10.1038\/s41467-021-26472-9","volume":"12","author":"JL Vos","year":"2021","unstructured":"Vos JL, Elbers JBW, Krijgsman O, Traets JJH, Qiao X, van der Leun AM, Lubeck Y, Seignette IM, Smit LA, Willems SM, van den Brekel MWM, Dirven R, Baris Karakullukcu M, Karssemakers L, Klop WMC, Lohuis PJFM, Schreuder WH, Smeele LE, van der Velden LA, Bing Tan I, Onderwater S, Jasperse B, Vogel WV, Al-Mamgani A, Keijser A, van der Noort V, Broeks A, Hooijberg E, Peeper DS, Schumacher TN, Blank CU, de Boer JP, Haanen JBAG, Zuur CL. Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma. Nat Commun. 2021;12:7348.","journal-title":"Nat Commun"},{"key":"16348_CR12","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1038\/s41467-024-46444-z","volume":"15","author":"D Wu","year":"2024","unstructured":"Wu D, Li Y, Xu P, Fang Q, Cao F, Lin H, Li Y, Su Y, Lu L, Chen L, Li Y, Zhao Z, Hong X, Li G, Tian Y, Sun J, Yan H, Fan Y, Zhang X, Li Z, Liu X. Neoadjuvant chemo-immunotherapy with camrelizumab plus nab-paclitaxel and cisplatin in resectable locally advanced squamous cell carcinoma of the head and neck: a pilot phase II trial. Nat Commun. 2024;15:2177.","journal-title":"Nat Commun"},{"key":"16348_CR13","doi-asserted-by":"crossref","unstructured":"Fang Q, Yuan J, Huang T. Contralateral neck metastasis in lateralized cT3\/4N0 oral squamous cell carcinoma. J Craniomaxillofac Surg. 2025;53:222\u20137.","DOI":"10.1016\/j.jcms.2024.12.008"},{"key":"16348_CR14","doi-asserted-by":"publisher","first-page":"107149","DOI":"10.1016\/j.oraloncology.2024.107149","volume":"161","author":"Q Fang","year":"2024","unstructured":"Fang Q, Yuan J, Zhang X, Dai L, Luo R, Huang T. Omitting elective neck dissection in cT1\/2N0 oral squamous cell carcinoma with sentinel lymph node metastasis: A prospective study. Oral Oncol. 2024;161:107149.","journal-title":"Oral Oncol"},{"key":"16348_CR15","doi-asserted-by":"publisher","first-page":"106810","DOI":"10.1016\/j.oraloncology.2024.106810","volume":"152","author":"Q Fang","year":"2024","unstructured":"Fang Q, Yuan J, Zhang X, Dai L, Luo R, Xu C. Oncologic and functional results between sentinel lymph node biopsy and elective neck dissection in cT1\/2N0 maxillary squamous cell carcinoma. Oral Oncol. 2024;152:106810.","journal-title":"Oral Oncol"},{"key":"16348_CR16","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1016\/j.ymthe.2024.09.026","volume":"32","author":"D Lee","year":"2024","unstructured":"Lee D, Cho M, Kim E, Seo Y, Cha JH. PD-L1: From cancer immunotherapy to therapeutic implications in multiple disorders. Mol Ther. 2024;32:4235\u201355.","journal-title":"Mol Ther"},{"key":"16348_CR17","doi-asserted-by":"publisher","first-page":"106918","DOI":"10.1016\/j.oraloncology.2024.106918","volume":"156","author":"X Zhao","year":"2024","unstructured":"Zhao X, Zhou Y, Peng G, Wen L, Hong X, Hu Y, Wu B, Liu X, Zhang Z, Xiao G, JingHuang, Ding Q, Yang C, Xiong X, Ma H, Shi L, Yang J, Wei J, Qin Y, Wan C, Zhong Y, Leng Y, Zhang T, Wu G, MinYao, Jia Y, Zhang X, Yang K. Final analysis of a phase II trial of neoadjuvant chemoimmunotherapy for locoregionally advanced head and neck squamous cell carcinoma. Oral Oncol. 2024;156:106918.","journal-title":"Oral Oncol"},{"key":"16348_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","volume":"62","author":"LH Schwartz","year":"2016","unstructured":"Schwartz LH, Liti\u00e8re S, de Vries E, Ford R, Gwyther S, Mandrekar S, Shankar L, Bogaerts J, Chen A, Dancey J, Hayes W, Hodi FS, Hoekstra OS, Huang EP, Lin N, Liu Y, Therasse P, Wolchok JD, Seymour L. RECIST 1.1-Update and clarification: From the RECIST committee. Eur J Cancer. 2016;62:132\u20137.","journal-title":"Eur J Cancer"},{"key":"16348_CR19","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1007\/s13197-024-05966-6","volume":"61","author":"M Ji","year":"2024","unstructured":"Ji M, Zhang L, Bao HH, Chen HM, Wu Y, Hu XS, Chen F, Zhu YC. Exposure assessment to areca alkaloids in the Chinese populations through areca nut chewing. J Food Sci Technol. 2024;61:1894\u2013904.","journal-title":"J Food Sci Technol"},{"key":"16348_CR20","doi-asserted-by":"crossref","unstructured":"Hashmi AA, Mudassir G, Rashid K, Malik UA, Zia S, Zia F, Irfan M. Risk Factors of Oral Squamous Cell Carcinoma with Special Emphasis on Areca Nut Usage and Its Association with Clinicopathological Parameters and Recurrence. Int J Surg Oncol. 2024; 2024:9725822.","DOI":"10.1155\/2024\/9725822"},{"key":"16348_CR21","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/(SICI)1097-0142(19961101)78:9<1972::AID-CNCR19>3.0.CO;2-V","volume":"78","author":"HM Wang","year":"1996","unstructured":"Wang HM, Ng SH, Wang CH, Liaw CC, Tsai MH, Lai GM. Correlation between computed tomographic density of lymph node metastases and response to cisplatin-based chemotherapy in patients with head and neck squamous cell carcinoma in an area in which betel quid chewing is prevalent. Cancer. 1996;78:1972\u20139.","journal-title":"Cancer"},{"key":"16348_CR22","doi-asserted-by":"publisher","first-page":"e002485","DOI":"10.1136\/jitc-2021-002485","volume":"9","author":"R Leidner","year":"2021","unstructured":"Leidner R, Crittenden M, Young K, Xiao H, Wu Y, Couey MA, Patel AA, Cheng AC, Watters AL, Bifulco C, Morris G, Rushforth L, Nemeth S, Urba WJ, Gough M, Bell RB. Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma. J Immunother Cancer. 2021;9:e002485.","journal-title":"J Immunother Cancer"},{"key":"16348_CR23","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.3390\/ijerph20032392","volume":"20","author":"G Feller","year":"2023","unstructured":"Feller G, Khammissa RAG, Ballyram R, Beetge MM, Lemmer J, Feller L. Tumour Genetic Heterogeneity in Relation to Oral Squamous Cell Carcinoma and Anti-Cancer Treatment. Int J Environ Res Public Health. 2023;20:2392.","journal-title":"Int J Environ Res Public Health"},{"key":"16348_CR24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/ajco.13971","volume":"20","author":"D Zhu","year":"2024","unstructured":"Zhu D, Huang Z, Xiao K, Bian D, Zhang J, Zhang Z, Zhu S, Yin L, Zhu J, Zhang P. Does the number of cycles of neoadjuvant therapy affect the efficacy of neoadjuvant chemoimmunotherapy for non-small cell lung cancer in locally advanced stage? Retrospective experience based on a single center. Asia Pac J Clin Oncol. 2024;20:643\u201351.","journal-title":"Asia Pac J Clin Oncol"},{"key":"16348_CR25","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1111\/1759-7714.14867","volume":"14","author":"J Chen","year":"2023","unstructured":"Chen J, Ang KL, Wang Z, Lei F, He J, Li S. Impacts of additional cycles of neoadjuvant immunotherapy on surgery in non-small-cell lung cancer. Thorac Cancer. 2023;14:1260\u20137.","journal-title":"Thorac Cancer"},{"key":"16348_CR26","doi-asserted-by":"publisher","first-page":"e246837","DOI":"10.1001\/jamanetworkopen.2024.6837","volume":"7","author":"GL Banna","year":"2024","unstructured":"Banna GL, Hassan MA, Signori A, Giunta EF, Maniam A, Anpalakhan S, Acharige S, Ghose A, Addeo A. Neoadjuvant Chemo-Immunotherapy for Early-Stage Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2024;7:e246837.","journal-title":"JAMA Netw Open"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16348-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16348-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16348-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:03:37Z","timestamp":1788782617000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16348-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16348"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16348-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"1 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by Henan Cancer Hospital Hospital Institutional Research Committee (No. 202533CGF), and written informed consent for medical research was obtained from all patients prior to initial treatment. All methods were performed in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1064"}}